Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D02ONP
|
||||
Former ID |
DNC010005
|
||||
Drug Name |
Ethyl Bis(4-hydroxy-2-oxo-2H-chromen-3-yl)acetate
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Discovery agent | Investigative | [530490] | ||
Structure |
Download2D MOL |
||||
Formula |
C21H14O8
|
||||
Canonical SMILES |
COC(=O)C(C1=C(C2=CC=CC=C2OC1=O)O)C3=C(C4=CC=CC=C4OC3=O)<br />O
|
||||
InChI |
1S/C21H14O8/c1-27-19(24)14(15-17(22)10-6-2-4-8-12(10)28-20(15)25)16-18(23)11-7-3-5-9-13(11)29-21(16)26/h2-9,14,22-23H,1H3
|
||||
InChIKey |
XCIPOAZOZKLEOW-UHFFFAOYSA-N
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | NAD(P)H dehydrogenase [quinone] 1 | Target Info | Inhibitor | [530490] | |
KEGG Pathway | Ubiquinone and other terpenoid-quinone biosynthesis | ||||
NetPath Pathway | TCR Signaling Pathway | ||||
Pathway Interaction Database | Validated transcriptional targets of TAp63 isoforms | ||||
PathWhiz Pathway | Vitamin K Metabolism | ||||
WikiPathways | Estrogen metabolism | ||||
Oxidative Stress | |||||
Transcriptional activation by NRF2 | |||||
NRF2 pathway | |||||
Nuclear Receptors Meta-Pathway | |||||
Aryl Hydrocarbon Receptor Pathway | |||||
Apoptosis-related network due to altered Notch3 in ovarian cancer | |||||
Metabolism of amino acids and derivatives | |||||
Aryl Hydrocarbon Receptor | |||||
Dopamine metabolism | |||||
Arylhydrocarbon receptor (AhR) signaling pathway | |||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.